Extracellular matrix metalloproteinase 2 levels are regulated by the low density lipoprotein-related scavenger receptor and thrombospondin 2.
We have recently shown that the adhesive defect observed in dermal fibroblasts derived from thrombospondin 2 (TSP2)-null mice results from an increase in matrix metalloproteinase 2 (MMP2) levels (Yang, Z., Kyriakides, T. R., and Bornstein, P. (2000) Mol. Biol. Cell 11, 3353-3364). Adhesion was restored by replacement of TSP2 and by inhibitors of MMP2 activity. In pursuing the observation that TSP2 and MMP2 interact, we now demonstrate that this interaction is required for optimal clearance of extracellular MMP2 by fibroblasts. Since TSP2 is known to be endocytosed by the scavenger receptor, low density lipoprotein receptor-related protein (LRP), we determined whether interference with LRP function affected fibroblast adhesion and/or extracellular MMP2 levels. Addition of heparin, which competes for the binding of TSP2 to LRP coreceptor proteoglycans, inhibited adhesion of control but not TSP2-null cells, and a blocking antibody to LRP as well as the LRP inhibitor, receptor-associated protein, also inhibited adhesion and increased MMP2 levels only in control fibroblasts. TSP2 did not inhibit active MMP2 directly and did not inhibit the activation of pro-MMP2. Finally, the internalization of 125I-MMP2 was reduced in TSP2-null compared with control fibroblasts. We propose that clearance of MMP2-TSP2 complexes by LRP is an important mechanism for the regulation of extracellular MMP2 levels in fibroblasts, and perhaps in other cells. Thus, some features of the phenotype of TSP2-null mice, such as abnormal collagen fibrillogenesis, accelerated wound healing, and increased angiogenesis, could result in part from increased MMP2 activity.
Yang
Z
Z
Department of Biochemistry, the University of Washington, Seattle, Washington 98195, USA.
Strickland
D K
DK
Bornstein
P
P
D000818:Animals; D002448:Cell Adhesion; D002478:Cells, Cultured; D005347:Fibroblasts / Q000378:metabolism; D026503:Low Density Lipoprotein Receptor-Related Protein-1; D020778:Matrix Metalloproteinase 2 / Q000032:analysis*; D051379:Mice; D018919:Neovascularization, Physiologic; D010662:Phenylmercuric Acetate / Q000031:analogs & derivatives* / Q000494:pharmacology; D011971:Receptors, Immunologic / Q000502:physiology*; D019700:Thrombospondin 1 / Q000502:physiology; D019699:Thrombospondins / Q000502:physiology*; D000099262:Thrombospondin 2
D026503:Low Density Lipoprotein Receptor-Related Protein-1; D020778:Matrix Metalloproteinase 2; D010662:Phenylmercuric Acetate; D011971:Receptors, Immunologic; D019700:Thrombospondin 1; D019699:Thrombospondins; D000099262:Thrombospondin 2; C010024:4-aminophenylmercuriacetate